EMA Authorised: Fetcroja (cefiderocol sulfate tosilate) — Shionogi B.V.

View source ↗

Summary

EU authorisation of Fetcroja (cefiderocol) for Gram-negative bacterial infections, marking regulatory approval for this antimicrobial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacterial Infections

Drugs mentioned

• Fetcroja (cefiderocol)

Snippet

Status: Authorised. Therapeutic area: Gram-Negative Bacterial Infections. MAH: Shionogi B.V.. Decision date: 13/01/2025